Position in ABCL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,201,999
+$1,984,066 QoQ
Shares Held
407,898
+16.9% QoQ
Ownership
0.133%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#29
of 150 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABCL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026OSAIC HOLDINGS, INC. holds $237,726,632 across 405 Biotechnology names. ABCL ranks #18 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LGND |
Ligand Pharmaceuticals Inc
|
90,236 | $28,522,697 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
49,586 | $24,630,851 | |
| 3 | TGTX |
Tg Therapeutics, Inc.
|
372,588 | $20,469,983 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
217,577 | $16,205,134 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
176,973 | $13,851,674 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
45,298 | $13,636,055 | |
| 7 | VCEL |
Vericel Corp
|
182,038 | $8,098,869 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
12,423 | $7,746,234 |
All Filings in ABCL
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,201,999 | 407,898 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,217,933 | 348,978 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,187,837 | 347,321 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,725,667 | 343,075 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $919,243 | 268,001 | Shares | Defined | 2025-09-04 | |
| 2025-03-31 | $481,176 | 215,774 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $386,800 | 132,014 | Shares | Defined | 2025-06-06 | |
| 2024-09-30 | $271,060 | 104,254 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $315,171 | 106,477 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $474,956 | 104,847 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $583,320 | 102,158 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $909,838 | 197,791 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $586,701 | 90,821 | Shares | Defined | 2023-08-21 | |
| 2023-03-31 | $636,751 | 84,450 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $756,365 | 74,666 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $690,983 | 69,867 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $516,854 | 48,531 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $396,814 | 40,699 | Shares | Defined | 2022-05-04 | |
| 2021-12-31 | $383,553 | 26,822 | Shares | Defined | 2022-02-03 | |
| 2021-09-30 | $262,203 | 13,084 | Shares | Defined | 2021-11-05 | |
| 2021-06-30 | $134,134 | 6,097 | Shares | Defined | 2021-08-02 | |
| 2021-03-31 | $155,231 | 4,571 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $58,348 | 1,450 | Shares | Defined | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||